Related Experiment Video

Updated: Nov 29, 2025

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.7K

Metabolic Compartmentalization at the Leading Edge of Metastatic Cancer Cells

Kara Wolfe1,2, Ryo Kamata3,4, Kester Coutinho5

  • 1Division of Hematology and Oncology, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH, United States.

Frontiers in Oncology
|November 23, 2020
PubMed

Insights

Cancer cells use membraneless metabolic compartmentalization to spread. This process, particularly purine nucleotide metabolism at the cell's leading edge, drives tumor metastasis and may offer new therapeutic targets.

Area of Science:

  • Oncology
  • Cell Biology
  • Metabolic Regulation

Background:

  • Metastasis remains a major challenge in cancer treatment despite therapeutic advances.
  • Metabolic reprogramming is linked to cancer metastasis, but its spatial and temporal regulation is understudied.
  • Understanding how intracellular metabolism drives cancer cell migration and invasion is crucial.

Purpose of the Study:

  • To highlight membraneless metabolic compartmentalization as a key mechanism in cancer metastasis.
  • To focus on the compartmentalization of purine nucleotide metabolism in migrating cancer cells.
  • To explore the role of phase-separated microdomains in regulating metabolic enzymes.

Main Methods:

  • Review of current literature on cancer metastasis and cellular metabolism.
  • Focus on the concept of membraneless metabolic compartmentalization.
  • Analysis of purine nucleotide metabolism at the leading edge of migrating cancer cells.

Main Results:

  • Membraneless metabolic compartmentalization is identified as a critical factor in cancer cell metastatic capacity.
  • Purine nucleotide metabolism (ATP, GTP) is compartmentalized at the leading edge of migrating cancer cells.
  • Phase-separated microdomains facilitate dynamic enzyme exchange, regulating metabolism.

Conclusions:

  • Membraneless metabolic compartmentalization is a vital mechanism driving tumor metastasis.
  • Targeting metabolic compartmentalization offers a novel therapeutic strategy against cancer spread.
  • Future research into these metabolic microdomains could lead to new anti-metastasis treatments.
Keywords:
GTP-metabolismcancerleading edgeliquid-liquid phase separationmembraneless metabolic compartmentalizationmetabolonmetastasispurine biosynthesis

More Related Videos

Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread05:23

Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread

Published on: July 7, 2023

1.4K
Evaluation of Cancer Stem Cell Migration Using Compartmentalizing Microfluidic Devices and Live Cell Imaging09:36

Evaluation of Cancer Stem Cell Migration Using Compartmentalizing Microfluidic Devices and Live Cell Imaging

Published on: December 23, 2011

25.6K

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.1K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.4K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.8K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.0K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.5K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.4K